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Abstract 
  
At this time there is an increasing demand for an accurate pre operative staging in non small cell lung cancer. Chest 
Computed Tomography (CT) is one of the imaging modality of choice used for this purpose. This study evaluated the 
accuracy of the chest CT to determine the status of the tumor and nodules in non small cell lung cancer. During the 
years 1998 and 1999, a descriptive prospective study of 32 patients undergoing a contrast enhanced chest CT 
examination for non small cell lung cancer, stage I-IIIA, was conducted. Lobectomy, lymph nodes dissection and 
postoperative histo-pathological examination were done. CT findings were as follows: a sensitivity of 100%, a 
specificity of 25% and an accuracy of 60% in the detection of the nodule stage were found. In 17 patients with adeno-
carcinoma, the sensitivity, the specificity and the accuracy were 86.6%, 100% and 88.2% respectively. The diagnosis of 
all patients was confirmed histo-pathologically. Six patients with T2 and 26 patients with T3 were detected by chest CT; 
the accuracy of the tumor status was 93.7%, confirmed by surgical and histo-pathological examinations. It was 
concluded that the CT played an important role in determining the clinical stage of non small cell lung cancer. The 
specificity and accuracy were higher in adeno-carcinoma as compared with squamous cell carcinoma in detecting the 
nodal status.  
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1. Introduction 
 
According to American Cancer Society (A.C.S) in USA, 
lung cancers are the most common site of cancer, 
regarding both mortality and incidence, with an 
estimated rate of 153.000 deaths and 172.000 new cases 
in 1994. The mortality of lung cancer rose rapidly from 
7 per 100.000 in the population in 1940 to 50 per 
100.000 in the year 1990. Only 16% of lung cancers 
were early detected, with a survival rate of 46%1. The 
most often detected type was the non small cell lung 
cancer (NSCLC) 1-4. 
 
At this time there is an increasing demand for accurate 
preoperative staging of the lung cancers, the so-called 
clinical staging 2,6-8. It is based on the assessment of the 
anatomic extent of the disease before establishing 
definitive therapy. This covered the assessment of plain 
chest X-ray examination, CT scan of the chest with 
contrast medium, endoscopic studies including 
bronchoscopy, mediastinoscopy and other tests, 
designed to demonstrate extra thoracic metastasis. The 
status of the tumor and regional lymph nodes, as well as 
the mapping scheme of lymph nodes are major issues 
for staging, assigning and evaluating treatment efficacy 
in patients with lung cancer3,9-11. Tumor (T) and nodal 
(N) stages are determined according to the assessment 
and judgment of radiologist.  
 
Anatomic imaging modality, such as chest and upper 
abdominal CT should be applied for this reason. CT 
could detect the detail of the anatomy of the T, the N 
status, and also lung, pleural and upper abdominal 
metastasis1-3,6-8,9-13. 
 
Studies showed that chest CT had a high accuracy and 
sensitivity. N status could be detected in 70 - 90 %, 
therefore the accuracy rate was 85% in revealing the 
stage of the primary T 2.6.7.13.  Authors reported that the 
clinical stage decreased and the survival rate increased 
due to giving neo adjuvant therapy during stage IIIA 
NSCLC. For these reasons, an accurate clinical staging 
has been needed14. Besides clinical staging, there is 
pathologic staging. It is based on the information 
obtained from clinical staging, findings at surgical and 
examination of the resected specimens including lymph 
nodes3. 
  
The purpose of this study was to know the accuracy, 
sensitivity and specificity of chest CT in detecting the 
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stage of the T and the N of stage I – III A of type 
NSCLC, with histo-pathologic anatomy as the gold 
standard.  
 
2. Material and Methods  
 
In Persahabatan Hospital, 237 new cases of lung cancer 
in 1998 and 294 cases in 1999, including only 32 (6%) 
cases stage I-IIIA and 499 (94%) cases stage IIIB to IV, 
were found. The most frequently observed type was 
type NSCLC (72.6 %)4,5. In this descriptive prospective 
study, conducted from January 1998 to December 1999, 
32 patients with suggested type NSCLC, clinical stage I 
- III A according to TNM UICC 1997 criteria, who 
underwent surgery, were included. The cases consisted 
of 24 males and 8 females between 32 and 65 years old 
with a mean age of 48.5 years. The clinical stage I - III 
A NSCLC was determined by the medical history, 
physical examination, sputum cytology, bronchoscopy, 
trans-thoracal biopsy and various imaging procedures 
such as chest radiography, chest and upper abdominal 
CT. Bone scanning, abdominal USG and brain CT were 
done to exclude metastasis. 
 
The status of the T and the N were established 
according to reports on radiological findings from 
thoracic and upper abdominal CT examination, 
following AJCC / TNM UICC 1997. CT was performed 
on General Electric Helical Sytec SRI. Standard 
protocol CT involved imaging from apical lung to upper 
abdominal area, with slice thickness of 10 mm and 
interval of 10 mm. In the hilar area, the slice thickness 
was 5 mm and the interval 5mm. CT scan was obtained 
using non-enhanced and enhanced scans.  
 
The criteria of lymph nodes enlargement were as 
follows: size more than 1cm, peripheral enhancement or 
no enhancement after enhanced CT. Report of the N 
status according to mapping of lymph nodes.  The stage 
of the tumor T2 and T3 were made according to TNM 
criteria. Some criteria, used for excluding T4, were as 
follows: extension of the tumor to the mediastinum not 
more than 3cm, extension of the tumor to the vascular 
system not more then 90 degree.   
 
Clinical stage means stage before operation, included 
chest x ray, cytology sputum, chest and upper 
abdominal CT, bronchoscopy, TTB, bone scanning, 
abdominal USG, and brain CT.  
 
The operation was done not more than 1 month after the 
CT examination and clinical staging. Type of surgery 
was complete resection and homo lateral lymph nodes 
dissection.  
 
The histo-pathologic stage was based on the information 
obtained from clinical staging, findings at the operation 
and at the pathologic examination of the resected 
specimen, including lymph nodes. The result of the 
clinical stage was compared by the histo-pathologic 
stage as the gold standard.     
 
True positive were patients with positive lymph nodes 
enlargement, observed at the CT as well as at the 
operation and afterwards proven by histo-pathologic 
examination. True negative meant patients with 
negative lymph nodes enlargement, determined by CT 
and   by surgery, as well as proven by histo-pathologic 
examination. False positive were patients with positive 
lymph nodes enlargement, discovered by CT and during 
operation, however the histo-pathologic specimen was 
negative. False negative meant patients with negative 
lymph nodes enlargement by the CT and at the 
operation, however the histo-pathologic specimen was 
positive. 
 
True positive of the tumor meant patient with T3 by CT 
and according to findings at surgery. True negative of 
the tumor meant patient with T2 by CT and to findings 
at the operation. False positive of the tumor were patient 
with T3 by CT and T2 during the operation. False 
negative of the tumor meant patient with T2, T3 by CT 
and T3, T4 at surgery. 
 
3. Results 
                              
The clinical stage among the 32 patients was as follows: 
3 patients, stage IB (T2 N0 M0), 3 patients IIB (T3 N0 
M0) and 26 patients with clinical stage IIIA (T3 N1 M0: 
1 patient, T3 N2 M0: 22 patients and T2 N2 M0: 3 
patients).      
 
The location of the tumor was in the right upper lobe, in 
the right lower lobe, in the right middle lobe, in the left 
upper lobe, in the left lower lobe in respectively 14, 7, 
2, 7 and in 2 patients. Therefore the tumor was found in 
the right lobe in 23 patients and in 9 patients the tumor 
was located in the left lobe.    
 
The histo-pathologic type of the tumors was squamous 
cell carcinoma in 15 patients and adeno-carcinoma in 17 
patients. 
 
Before operation, we found 26 patients with T3 and 6 
patients with T2 by CT, and after the operation 24 
patients with T3, and 8 patients with T2. Two patients 
with T3 were proven by surgery to be T2. The findings 
at CT about the N status were as follows: 25 patients N2 
positive, 1 patient N1 positive and 6 patients N0. After 
the operation, it was found that among 6 patients N0, 4 
were negative, whereas 2 patients were positive by 
histo-pathologic examination. From 26 N positive 
before operation, we found 17 patients positive and 9 
patients negative by histo-pathologic examination.   
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Table 1. The correlation of N status positive, between CT and histo-pathologic (PA) findings 
 
             CT               PA  
Squamous cell ca       13 patients      7   patients 
Adeno ca       13 patients      13   patients 
Total       26 patients      20 patients 
 
 
Table 2.  The correlation of the N status negative, between CT and histo-pathologic findings 
 
           CT          PA  
Squamous cell ca       2 patients      2 patients 
Adeno ca       4 patients      2 patients 
Total       6 patients      4 patients 
  
 
Table 3. The correlation of the T status between CT and Surgery 
 
T Stage Chest CT Surgery 
T2 6   
( 2 adeno,4SCC ) 
6 
( 2 adeno,4SCC ) 
T3 26  
(15 adeno, 11SCC) 
24 
( 13 adeno,11 SCC) 
Total 32 
( 17 adeno, 15 SCC) 
30 
( 17 adeno, 11SCC) 
Note : SCC = Squamous cell carcinoma 
 
 
Table 4. Evaluation of the N status by CT and histo-pathologic findings 
 
 SCC  Adeno Ca Total 
True positive  7 13 20 
False positive  6   0   6 
True negative  2  2  4
False negative  0   2   2 
 Total   15  17  32 
 
 
Table 5. Evaluation of the T stage by CT and surgical findings 
 
 SCC Adeno Ca Total 
True positive 11 13 24 
False positive  0 2  2
True negative  4  2   6 
False negative  0  0   0 
Total 15 17 32 
 
 
Table 4 shows the N status by CT and histo pathology. 
True positive  SCC and Adeno CA are 62.50%.  
 
Table 5 shows the true positive T stage by CT and  
surgical findings are 75%.  
 
In detecting the T stage, chest CT had a sensitivity, a 
specificity and an accuracy of 100 %, 75% and 93.7% 
respectively.   
 
In this study chest CT had a sensitivity, a specificity and 
an accuracy in detecting the N status as follows: the 
sensitivity in squamous cell carcinoma was 100 %, the 
specificity was 25%, and the accuracy was 60%. In 
adeno-carcinoma the sensitivity was 86.6%, the 
specificity was 100% and the accuracy was 88.2 %. 
 
Totally, in both adeno and squamous cell carcinoma, the 
sensitivity was 90.9%, the specificity was 40 % and the 
accuracy was 75%.  
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Case 1. 
Chest CT of a 59 year old man with clinical stage 
T3N0M0 of the squamous cell ca on the right upper 
lung. After surgical resection of the tumor and nodal, 
the pathologic stage was same.  
 
 
 
 
 
 
 
 
Case 2.  
Chest CT of a 62 year old man with clinical stage 
T3N2M0 of adeno ca on the right upper lung. After 
surgical resection of the tumor and nodal, the pathologic 
stage was same. 
 
 
 
 
 
 
 
 
 
Case 3.  
Chest CT of a 65 year old man with clinical stage T3 N2 
M0 of adeno ca on the left lower lung. After surgical 
resection of the tumor and  nodal,  the pathologic stage 
was T2N2 MO, there is no extension of the tumor to the 
chest wall. 
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4. Discussion  
 
From 32 patients of our study, the accuracy of chest CT 
in detecting the T stage was 93.7%, compared to 
another study of about 85%. the accuracy of chest CT to 
detect the N status was 75%. This finding is almost the 
same as others studies which reported the accuracy of 
CT about 70%6. Other studies reported an accuracy of 
90%2.  According to our opinion, the difference of the 
result was possibly due to the small number of cases in 
our study. Especially for the negative findings by CT, 
the sensitivity and the specificity were higher. Like 
other studies, if the nodal status was negative by CT, 
thoracotomy has to be done immediately. Some studies 
have been reported, that only 7% of patients with 
normal size lymph nodes possibly have metastasis14. In 
cases with adeno-carcinoma, if there were lymph nodes 
enlargement (N2), detected by CT, the neo adjuvant 
therapy must be considered before the operation, to 
increase the survival rate of the patients. The neo 
adjuvant therapy in squamous carcinoma was not 
decided before the operation, because of high numbers 
with false positive results. Especially in patients who 
live in geographic regions where granulomatous 
diseases is prevalent, the enlarge nodes are more likely 
to be benign than malignant. So in squamous carcinoma, 
the lymph nodes enlargement must be verified, before 
giving neo adjuvant therapy14.         
 
5. Conclusions 
 
CT has to be done in NSCLC in order to determine the 
clinical staging. Also CT is useful in identifying T status 
and macroscopic mediastinal and hilar nodal 
enlargement. In detecting the T status, the accuracy of 
CT was 93.7%, the sensitivity 100% and specificity 
75%. The accuracy of CT was 75% and its sensitivity 
was 100 % in the detection of the nodal status of the 
NSCLC type. If the nodal status was negative by CT, 
thoracotomy has to be done immediately. The level of 
specificity of CT to detect the N status was higher in 
adeno carcinoma as compared to that of squamous cell 
carcinoma (100% vs 25%).  
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